Trial record 1 of 1 for:    NCT01609283
Previous Study | Return to List | Next Study

A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01609283
Recruitment Status : Active, not recruiting
First Posted : May 31, 2012
Last Update Posted : January 12, 2018
Information provided by (Responsible Party):
Anthony J. Windebank, Mayo Clinic